Homologous repair of DNA damage and tumorigenesis: the BRCA connection - PubMed (original) (raw)

Review

. 2002 Dec 16;21(58):8981-93.

doi: 10.1038/sj.onc.1206176.

Affiliations

• PMID: 12483514
• DOI: 10.1038/sj.onc.1206176

Review

Homologous repair of DNA damage and tumorigenesis: the BRCA connection

Maria Jasin. Oncogene. 2002.

Abstract

Homologous recombination has been recognized in recent years to be an important DNA repair pathway in mammalian cells, for such damage as chromosomal double-strand breaks. Cells mutated for the genes involved in the hereditary breast and ovarian cancer susceptibility syndromes, i.e. BRCA1 and BRCA2, show defects in DNA repair by homologous recombination, implicating this repair pathway in protecting individuals against tumorigenesis. This review summarizes recent advances in our understanding of BRCA1 and BRCA2 in DNA repair, as well as insight into these proteins gleaned from structure determination of domains of these proteins and the broader evolutionary conservation than previously appreciated.

PubMed Disclaimer

Similar articles

• Homologous recombination and human health: the roles of BRCA1, BRCA2, and associated proteins.
  Prakash R, Zhang Y, Feng W, Jasin M. Prakash R, et al. Cold Spring Harb Perspect Biol. 2015 Apr 1;7(4):a016600. doi: 10.1101/cshperspect.a016600. Cold Spring Harb Perspect Biol. 2015. PMID: 25833843 Free PMC article. Review.
• Therapeutic exploitation of tumor cell defects in homologous recombination.
  Powell SN, Kachnic LA. Powell SN, et al. Anticancer Agents Med Chem. 2008 May;8(4):448-60. doi: 10.2174/187152008784220267. Anticancer Agents Med Chem. 2008. PMID: 18473729 Review.
• Genetic steps of mammalian homologous repair with distinct mutagenic consequences.
  Stark JM, Pierce AJ, Oh J, Pastink A, Jasin M. Stark JM, et al. Mol Cell Biol. 2004 Nov;24(21):9305-16. doi: 10.1128/MCB.24.21.9305-9316.2004. Mol Cell Biol. 2004. PMID: 15485900 Free PMC article.
• Minding the gap: the underground functions of BRCA1 and BRCA2 at stalled replication forks.
  Nagaraju G, Scully R. Nagaraju G, et al. DNA Repair (Amst). 2007 Jul 1;6(7):1018-31. doi: 10.1016/j.dnarep.2007.02.020. Epub 2007 Mar 26. DNA Repair (Amst). 2007. PMID: 17379580 Free PMC article. Review.
• The BRCA Tumor Suppressor Network in Chromosome Damage Repair by Homologous Recombination.
  Zhao W, Wiese C, Kwon Y, Hromas R, Sung P. Zhao W, et al. Annu Rev Biochem. 2019 Jun 20;88:221-245. doi: 10.1146/annurev-biochem-013118-111058. Epub 2019 Mar 27. Annu Rev Biochem. 2019. PMID: 30917004 Free PMC article. Review.

Cited by

• The BRCA mutation spectrum among breast and ovarian cancers in India: highlighting the need to screen BRCA1 185delAG among South Indians.
  John AO, Singh A, Yadav P, Joel A, Thumaty DB, Fibi Ninan K, Georgy JT, Cherian AJ, Thomas S, Thomas A, Thomas V, Peedicayil A, Varghese D, Parthiban R, Ravichandran L, Johnson J, Thomas N, Yadav B, Patricia S, Selvamani B, Abraham D, Paul MJ, Chacko RT, Chapla A. John AO, et al. Eur J Hum Genet. 2024 Mar 28. doi: 10.1038/s41431-024-01596-w. Online ahead of print. Eur J Hum Genet. 2024. PMID: 38538877
• Classification of MLH1 Missense VUS Using Protein Structure-Based Deep Learning-Ramachandran Plot-Molecular Dynamics Simulations Method.
  Tam B, Qin Z, Zhao B, Sinha S, Lei CL, Wang SM. Tam B, et al. Int J Mol Sci. 2024 Jan 10;25(2):850. doi: 10.3390/ijms25020850. Int J Mol Sci. 2024. PMID: 38255924 Free PMC article.
• Association Between Germline BRCA1/2 Gene Variants and Clinicopathological Features of Ovarian Cancer.
  Luo Y, Pan R, Rao H, Chen X, Yang H. Luo Y, et al. Int J Gen Med. 2024 Jan 11;17:75-84. doi: 10.2147/IJGM.S445660. eCollection 2024. Int J Gen Med. 2024. PMID: 38226182 Free PMC article.
• Targeting DNA repair for cancer treatment: Lessons from PARP inhibitor trials.
  Nambiar DK, Mishra D, Singh RP. Nambiar DK, et al. Oncol Res. 2023 Jun 27;31(4):405-421. doi: 10.32604/or.2023.028310. eCollection 2023. Oncol Res. 2023. PMID: 37415740 Free PMC article. Review.
• Contralateral breast cancer risk in patients with breast cancer and a germline-BRCA1/2 pathogenic variant undergoing radiation.
  van Barele M, Akdeniz D, Heemskerk-Gerritsen BAM; Genepso; Andrieu N, Noguès C; HEBON; van Asperen CJ, Wevers M, Ausems MGEM, de Bock GH, Dommering CJ, Gómez-García EB, van Leeuwen FE, Mooij TM; EMBRACE; Easton DF, Antoniou AC, Evans DG, Izatt L, Tischkowitz M, Frost D, Brewer C, Olah E, Simard J, Singer CF, Thomassen M, Kast K, Rhiem K, Engel C, de la Hoya M, Foretová L, Jakubowska A, Jager A, Sattler MGA, Schmidt MK, Hooning MJ. van Barele M, et al. J Natl Cancer Inst. 2023 Nov 8;115(11):1318-1328. doi: 10.1093/jnci/djad116. J Natl Cancer Inst. 2023. PMID: 37369040 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Nature Publishing Group

• Other Literature Sources

  • The Lens - Patent Citations

• Miscellaneous

  • NCI CPTAC Assay Portal